Holders · period archive

REGN · Regeneron Pharmaceuticals

Q1 2019 13F holders

← latest ownership dossier

Ticker: REGN
Type: Equity
Class: COM
Total reported value ($000, long equity)

Manager	Report date	Value	Shares